|Bid||0.00 x 800|
|Ask||76.09 x 1100|
|Day's Range||72.80 - 78.96|
|52 Week Range||18.52 - 79.72|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 06, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||76.67|
Twist Bioscience (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that its CEO and co-founder, Emily M. Leproust, Ph.D., will receive the 2020 Rosalind Franklin Award for Leadership at the Biotechnology Innovation Organization (BIO) IMPACT conference. The award will be presented on Tuesday, September 22, 2020 during a virtual fireside chat with Julianna Lemieux of Genetic Engineering News and the Rosalind Franklin Society.
It might be of some concern to shareholders to see the Twist Bioscience Corporation (NASDAQ:TWST) share price down 13...
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Jim Thorburn, CFO of Twist Bioscience, will present at the following upcoming virtual investor conferences: